BioNexus Gene Lab Corp — Investor Relations & Filings
Filings indexed
139
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
BGLC
BioNexus Gene Lab Corp. is a biotechnology company that specializes in precision diagnostics and gene-based technologies. The company focuses on the development and commercialization of advanced molecular diagnostics and genetic testing. Its core service involves non-invasive, blood-based dynamic genome screening for the early detection of an individual's susceptibility to certain diseases. Utilizing RNA research and screening facilities, BioNexus aims to identify health risks at their earliest stages to enable proactive health management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 10-Q | 2026-05-15 | English | |
| 10-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-04-14 | English | |
| 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-03-17 | English | |
| 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-02-23 | English | |
| 8-K Filing | 2026-02-03 | English | |
| FORM 8-K | 2025-12-30 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 46363257 | FORM 10-Q | 2026-05-15 | English | ||
| 34528034 | 10-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-04-14 | English | ||
| 32966568 | 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-03-17 | English | ||
| 32827482 | 8-K - BioNexus Gene Lab Corp (0001737523) (Filer) | 2026-02-23 | English | ||
| 31531100 | 8-K Filing | 2026-02-03 | English | ||
|
2025
10 filings
| |||||
| 13103873 | FORM 8-K | 2025-12-30 | English | ||
| 13103874 | FORM 8-K | 2025-12-23 | English | ||
| 13103875 | DEF 14A | 2025-12-03 | English | ||
| 13103878 | FORM 8-K | 2025-12-02 | English | ||
| 13103881 | FORM 10-Q | 2025-11-14 | English | ||
| 13103883 | PRE 14A | 2025-11-14 | English | ||
| 13103882 | FORM 8-K | 2025-11-13 | English | ||
| 13103885 | FORM 8-K | 2025-11-12 | English | ||
| 13103884 | FORM S-3 | 2025-11-07 | English | ||
| 13103887 | FORM 8-K | 2025-10-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
BioNexus Gene Lab Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35220/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35220 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35220 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35220 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35220}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioNexus Gene Lab Corp (id: 35220)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.